Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate


Latest News

Date posted: 3/14/2013

The blood thinner Pradaxa has been prescribed to millions of patients with atrial fibrillation in over 70 countries in the few short years it has been on the market.

Unfortunately, it has also been linked to over 600 deaths, as there is no antidote available for doctors to stop internal bleeding in patients.

Now, as hundreds of those affected have filed a Pradaxa lawsuit, drug maker Boehringer Ingelheim has started the early stages of developing an internal bleeding antidote for Pradaxa.

Health experts around the world continue to disagree about whether Pradaxa has higher risks for internal bleeding than warfarin or Coumadin.

The FDA has updated its reports to say the drug is just as safe as warfarin. However, the American College of Cardiology has warned that Pradaxa can have higher risks for bleeding complications compared to warfarin.

Recently, the Institute for Safe Medication Practices weighed in, ranking blood thinners like Pradaxa among the most dangerous drugs. They also studied over 18,000 reports of adverse events submitted to the FDA, and concluded that patients who suffer bleeding related to Pradaxa are nearly 5 times as likely to die than those with bleeding from warfarin.

In the past few months, the number of patients filing a Pradaxa lawsuit over serious or fatal internal bleeding has grown from 170 to 260, an increase of over 50%. Due to the number of cases, they have been consolidated to a special federal multi-district court in Illinois.

Now, the maker of Pradaxa, Boehringer Ingelheim, is in the first phase of clinical trials to test an antidote for Pradaxa internal bleeding.* Although bleeding antidotes exist for traditional blood thinners like warfarin, there is none for Pradaxa.

Regardless of their late efforts, those injured still have the right to seek compensation for their loss and treatment needs.

If you or a loved one have suffered internal bleeding after taking Pradaxa, it is important to speak with a lawyer about your legal options as soon as possible. Due to the specialized nature of these type of federal drug injury cases, DrugRisk only recommends lawyers who are already handling Pradaxa lawsuits.

Contact us today for more information on the research, side effects and litigation news related to Pradaxa, or to speak with a lawyer.